Drawing for ZTALMY ONE

USPTO serial 97321628

ZTALMY ONE

Reviewed by CopyMark Law Group

Reg. 7724551Status 700Registered
Filing date
Status date
Registration date
Mar 11, 2025
Examiner
HILLIARD, JESSICA LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZTALMY ONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith A. Barritt

Keith A. Barritt FISH & RICHARDSON P.C.P.O. BOX 1022MINNEAPOLIS, MN 55440-1022United States

Goods and services

ClassDescriptionStatusFirst use
035Administration of a discount program for enabling participating patients to obtain discounts on co-payments for drugs through use of a discount membership card; business administration assistance consultancy related to the preparation and submission of paperwork used to obtain prior authorization for medical and pharmaceutical insurance and the preparation and submission of paperwork documentation used to appeal the denial of medical and pharmaceutical insurance claims, all provided to physician offices and patientsACTIVEJul 28, 2022
036Charitable services, namely, providing financial support to patients via a program for the purpose of facilitating patient access to medication and helping patients pay for medications; providing insurance and financial information to health care providers and patients related to health insurance and sources of financial funding for health care, as well as insurance information related to insurance reimbursement of health care costs; insurance coverage services, namely, providing insurance information used to assist in identifying the scope of insurance coverage offered by patient medical and pharmaceutical insurance; insurance benefits eligibility verification services in the medical field; insurance consultation services, namely, providing insurance consultancy to assist physician offices and patients in obtaining prior authorization for medical and pharmaceutical insurance claims and to assist physician offices and patients to appeal denial of medical and pharmaceutical insurance claimsACTIVEJul 28, 2022
039Delivery of pharmaceutical prescriptions to patients after communication with patient pharmaciesACTIVEJul 28, 2022
044Preparation of patients' prescriptions in pharmacies provided after communication with patient's pharmacies; providing information to patients relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, all provided via communication with patient pharmaciesACTIVEJul 28, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 20, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 20, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 23, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 19, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 5, 2024IUAFUSE AMENDMENT FILED—
Nov 5, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 19, 2024EX3GSOU EXTENSION 3 GRANTED—
Apr 19, 2024EXT3SOU EXTENSION 3 FILED—
Apr 19, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 9, 2023EX2GSOU EXTENSION 2 GRANTED—
Nov 9, 2023EXT2SOU EXTENSION 2 FILED—
Nov 9, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 26, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2023EX1GSOU EXTENSION 1 GRANTED—
May 24, 2023EXT1SOU EXTENSION 1 FILED—
May 24, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 20, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 13, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2022DOCKASSIGNED TO EXAMINER—
Mar 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance